Iceland· IS-910075
Vidisic
A künstliche tränenflüssigkeit und sonstige indifferente präparate product containing carbomer, registered in Iceland by Gerhard Mann Dr., Chem.-pharm. Fabrik GmbH. The same ATC class is registered in 11 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Künstliche tränenflüssigkeit und sonstige indifferente präparate is registered in 11 of 19 countries.
Countries holding a registration under ATC S01XA20 (künstliche tränenflüssigkeit und sonstige indifferente präparate), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 7 of them publish a price we can compare per daily dose
Künstliche tränenflüssigkeit und sonstige indifferente präparate · ATC S01XA20
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Carbomer
- Manufacturer
- Gerhard Mann Dr., Chem.-pharm. Fabrik GmbH
- Country
- Iceland (IS)
- ATC code
- S01XA20
- ATC class
- Künstliche Tränenflüssigkeit und sonstige indifferente Präparate
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 1
1 priced- ean99760310 g x1 túpaISK 3699
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Künstliche tränenflüssigkeit und sonstige indifferente präparate in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandVidisicInPharm Sp. z o.o.
- SpainLIPOLASIC 2 mg/g GEL OFTALMICOLaboratoire Chauvin
- NetherlandsCarbomeer Medcor één dosis ooggel 2 mg/gMedcor Pharmaceuticals B.V.
- NorwayViscotearsOrifarm AS
- FinlandLiposicDr. Gerhard Mann, Chem.-pharm. Fabrik GmbH
- SwedenViscotears 2 mg/g ÖgongelDr. Gerhard Mann Chem.-pharm. Fabrik GmbH
- IrelandLiposic 2 mg/g eye gelBausch + Lomb Ireland Limited
- FranceLIPOSIC 2 mg/g, gel ophtalmiqueLABORATOIRE CHAUVIN
Authorised across Europe · EMA
The same active substance is authorised in 18 EEA countries. Names it is sold under:
- Austria · Carbomer Agepha
- Belgium · Liposic
- Germany · Carbomer Edo, Liposic
- Denmark · Viscotears
- Spain · Lipolasic
- Finland · Viscotears
- France · Aquarest, Lacrinorm
- United Kingdom (Northern Ireland) · Viscotears, Viscotears Single Dose Unit
- Greece · Liposic, Viscoter
- Ireland · Geltears, Liposic
- Italy · Lipovisc
- Luxembourg · Vidisic Edo, Vidisic®
- Netherlands · Liposic, Vidisic Carbogel
- Norway · Viscotears
- Poland · Vidisic
- Portugal · Liposic
- Sweden · Viscotears
- Slovakia · Vidisic
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b2f86508-e116-4db2-bd21-20e905c44a54 GET /v1/drugs/b2f86508-e116-4db2-bd21-20e905c44a54?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Augnhlaup",
"source": "lyfjastofnun",
"atc_raw": "S01XA20",
"marketed": false,
"strength": "2 mg/g",
"ma_number": "910075",
"substance": "Carbomer",
"other_info": null,
"legal_status": "(L) Ekki lyfseðilsskylt",
"ma_issued_serial": "34060"
}See everything about künstliche tränenflüssigkeit und sonstige indifferente präparate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.